These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26818647)

  • 21. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
    Harris JB; Holmes AP; Eiland LS
    Ann Pharmacother; 2021 Apr; 55(4):459-465. PubMed ID: 32885981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy.
    Bermas BL; Tassinari M; Clowse M; Chakravarty E
    Rheumatology (Oxford); 2018 Jul; 57(suppl_5):v2-v8. PubMed ID: 30137587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicians' Perspective of the New Pregnancy and Lactation Labeling Rule (PLLR): Results from an AAAAI/FDA Survey.
    Namazy J; Chambers C; Sahin L; Johnson T; Dinatale M; Lappin B; Schatz M
    J Allergy Clin Immunol Pract; 2020 Jun; 8(6):1947-1952. PubMed ID: 32084595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new FDA pregnancy labeling requirements for drugs.
    Frederiksen MC
    J Midwifery Womens Health; 2011; 56(3):303-7. PubMed ID: 21535377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA Implements New Labeling for Medications Used During Pregnancy and Lactation.
    Whyte J
    Am Fam Physician; 2016 Jul; 94(1):12-5. PubMed ID: 27386718
    [No Abstract]   [Full Text] [Related]  

  • 26. Providing adequate directions for medication use in pregnant women and nursing mothers: an overview of pregnancy labeling.
    Corbett K; Kremzner M; Stifano T
    J Am Acad Nurse Pract; 2011 Aug; 23(8):389-91. PubMed ID: 21790831
    [No Abstract]   [Full Text] [Related]  

  • 27. Medication use during pregnancy and lactation: the new FDA drug labeling.
    Tillett J
    J Perinat Neonatal Nurs; 2015; 29(2):97-9. PubMed ID: 25919597
    [No Abstract]   [Full Text] [Related]  

  • 28. A review of pregnancy and lactation postmarketing studies required by the FDA.
    Krastein J; Sahin L; Yao L
    Pharmacoepidemiol Drug Saf; 2023 Mar; 32(3):287-297. PubMed ID: 36401739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDA labeling system for drugs in pregnancy.
    Boothby LA; Doering PL
    Ann Pharmacother; 2001 Nov; 35(11):1485-9. PubMed ID: 11724104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule.
    Byrne JJ; Saucedo AM; Spong CY
    JAMA Netw Open; 2020 Aug; 3(8):e2015094. PubMed ID: 32865574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comparison of FDA and EMA Pregnancy and Lactation Labeling.
    Kappel D; Sahin L; Yao L; Thor S; Kweder S
    Clin Pharmacol Ther; 2023 Jun; 113(6):1251-1257. PubMed ID: 36645246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
    Gruber MF
    Vaccine; 2015 Nov; 33(47):6499-500. PubMed ID: 26256527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The need for contraception in patients taking prescription drugs: a review of FDA warning labels, duration of effects, and mechanisms of action.
    Zhang Z; Xu L; Zhang Z; Ding H; Rayburn ER; Li H
    Expert Opin Drug Saf; 2018 Dec; 17(12):1171-1183. PubMed ID: 30394114
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of Therapeutics in Pregnancy and Lactation.
    Eyal S
    Pharm Res; 2018 Mar; 35(5):107. PubMed ID: 29572667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication.
    Bradford WD; Kleit AN
    Health Econ; 2015 Jul; 24(7):859-75. PubMed ID: 25059655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
    Greene JA; Watkins ES
    N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical management of medications in pregnancy and lactation.
    Temming LA; Cahill AG; Riley LE
    Am J Obstet Gynecol; 2016 Jun; 214(6):698-702. PubMed ID: 26844758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
    Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
    Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of drugs in pregnancy.
    Knoppert D
    J Popul Ther Clin Pharmacol; 2011; 18(3):e506-12. PubMed ID: 22113261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.